Volume 14, Issue 1, Pages (January 2012)

Slides:



Advertisements
Similar presentations
Liver tumours due to endometriosis and endometrial stromal sarcoma
Advertisements

Volume 11, Issue 6, Pages (September 2009)
Robotic versus laparoscopic resection of liver tumours
Volume 9, Issue 6, Pages (December 2007)
Successful Treatment of Isolated Draining Intrahepatic Biliary Ducts in a Pediatric Liver Transplant Recipient Using Alcohol Sclerotherapy  Darice Liu,
Endoscopic treatment of bilhaemia following percutaneous liver biopsy
International Journal of Infectious Diseases
Volume 18, Issue 9, Pages (September 2016)
Volume 19, Issue 11, Pages (November 2017)
Volume 14, Issue 1, Pages (January 2012)
Biliary tract obstruction in chronic pancreatitis
Radiofrequency ablation in pancreatic cancer
Primary carcinoid tumour of the common bile duct
Hepatectomy for pyogenic liver abscess
Pancreatic acinar cell carcinoma presenting as acute pancreatitis
Volume 14, Issue 1, Pages (January 2012)
Volume 16, Issue 12, Pages (December 2014)
O.F. Bathe, C. Mies, D. Franceschi, J. Casillas, A.S. Livingstone  HPB 
Nikhil Amesur, MD, John S. Hammond, MD, Albert B. Zajko, MD, David A
Adrian B. Cresswell, Fenella K.S. Welsh, Myrddin Rees  HPB 
Volume 16, Issue 3, Pages (March 2014)
Volume 12, Issue 5, Pages (June 2010)
Optimization of Radioembolic Effect with Extended-shelf-life Yttrium-90 Microspheres: Results from a Pilot Study  Robert J. Lewandowski, MD, Ahsun Riaz,
P.B. Kekis, A. Kordonis, K.M. Stamou, B.P. Kekis  HPB 
Volume 10, Issue 5, Pages (October 2008)
New Indications for Endoscopic Radiofrequency Ablation
Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer
An Iatrogenic Metastasis
Annalisa K. Becker, MD, FRCPC, David K. Tso, MD, Alison C
Volume 65, Issue 4, Pages (April 2014)
Mohammad Howlader, Nigel Heaton, Mohamed Rela 
Morphologic Change in Computed Tomography of Aldosterone-Producing Adenoma After Radiofrequency Ablation  Ryan K.L. Lee, FRCR, Shirley Y.W. Liu, FRCS,
Volume 152, Issue 8, Pages (June 2017)
Pulmonary Ablation: A Primer
Volume 68, Issue 4, Pages (April 2018)
Volume 2, Issue 10, Pages (October 2017)
Carmel G. Cronin, Michael Moore, Michael A. Blake 
David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F
Theo Nicholaou, Rachel Wong, Ian D Davis  The Lancet 
Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients  David Schoemaker, Robert Black, Lynne.
Volume 3, Issue 5, Pages (May 2018)
Ashok K. Malani, MD, MS, Brian Olofsson, MD, David Debono, MD 
Ablative Technologies in the Management of Patients with Primary and Secondary Liver Cancer: An Overview  Nasir A. Khan, HBSc, Mark O. Baerlocher, MD,
A. Skiada, L. Vrana, H. Polychronopoulou, P. Prodromou, A. Chantzis, P
Routine Pre- and Post-Hematopoietic Stem Cell Transplant Computed Tomography of the Abdomen for Detecting Invasive Fungal Infection Has Limited Value 
Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer  Hiroyasu Kaneda, MD, PhD, Isamu.
Retrospective Review of Efficacy of Radiofrequency Ablation for Treatment of Colorectal Cancer Liver Metastases From a Canadian Perspective  Benjamin.
Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy 
High-frequency jet ventilation for minimizing breathing-related liver motion during percutaneous radiofrequency ablation of multiple hepatic tumours 
Quiz Page October 2007 American Journal of Kidney Diseases
Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis  Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD 
Evaluating Cryoablation of Metastatic Lung Tumors in Patients—Safety and Efficacy The ECLIPSE Trial—Interim Analysis at 1 Year  Thierry de Baere, MD,
Risk factors of incomplete thrombosis in the false lumen after endovascular treatment of extensive acute type B aortic dissection  Yong-Lin Qin, MD, Gang.
The Role of Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma  Andy K.W. Chan, MD, FRCPC, Chris Hegarty, MB,
Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib  Oana Pop, MD, Augustin Pirvu,
1000 consecutive ablation sessions in the era of computer assisted image guidance – Lessons learned  Marie Beermann, Johan Lindeberg, Jennie Engstrand,
Volume 148, Issue 7, Pages (June 2015)
Four-Year Complete Remission in a Patient with Metastatic Epidermal Growth Factor Receptor–Mutated Lung Cancer Treated with Two Cycles of Erlotinib  Brendan.
Osteoblastic Bone Lesions Developing During Treatment with Erlotinib Indicate Major Response in Patients with Non-small Cell Lung Cancer: A Brief Report 
The Incidental Pancreatic Cyst on Abdominal Computerized Tomography Imaging: Diagnosis and Management  William R. Brugge  Clinical Gastroenterology and.
Morphologic Change in Computed Tomography of Aldosterone-Producing Adenoma After Radiofrequency Ablation  Ryan K.L. Lee, FRCR, Shirley Y.W. Liu, FRCS,
Demonstration of persistent tumor cells 4 weeks after radiofrequency ablation of a pulmonary adenocarcinoma  Stéphane Renaud, Marco Schiavon, MD, Nicola.
Volume 3, Issue 5, Pages (May 2018)
Combined locoregional-immunotherapy for liver cancer
Matthew Reichert, MD, Eric S. Bensadoun, MD 
Treatment of an early type II endoleak causing hemorrhage after endovascular aneurysm repair for ruptured abdominal aortic aneurysm  Olivier Hartung,
Nishmi Gunasingam, MBBS, Philip I. Craig, MBBS, PhD, FRACP  VideoGIE 
Quiz page answers september 2003
Philip A. Linden, MD, Jon O. Wee, MD, Michael T
Percutaneous radiofrequency ablation of clinical stage I non–small cell lung cancer  Takao Hiraki, MD, Hideo Gobara, MD, Hidefumi Mimura, MD, Yusuke Matsui,
Presentation transcript:

Volume 14, Issue 1, Pages 60-66 (January 2012) Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis  Mohammed Shaheen, Mazen Hassanain, Murad Aljiffry, Tatiana Cabrera, Prosanto Chaudhury, Eve Simoneau, Nuttawut Kongkaewpaisarn, Ayat Salman, Juan Rivera, Mohammad Jamal, Robert Lisbona, Azzam Khankan, David Valenti, Peter Metrakos  HPB  Volume 14, Issue 1, Pages 60-66 (January 2012) DOI: 10.1111/j.1477-2574.2011.00405.x Copyright © 2012 International Hepato-Pancreato-Biliary Association Terms and Conditions

Figure 1 Therasphere therapy after surgical intervention. (a) An abdominal computed tomography (CT) scan showing a previously-treated neuroendocrine tumour (NET) metastatic lesion with radiofrequency ablation (RFA) in segment VII (white arrow) with no enhancement. However, multiple enhancing metastatic nodules (black arrow) are present adjacent to the ablated segment. (b) CT scan images of the same patient 3months after 90Y therapy of the right lobe of the liver showing a complete response. The vascular enhancement has virtually disappeared, but the lesions themselves are persistent HPB 2012 14, 60-66DOI: (10.1111/j.1477-2574.2011.00405.x) Copyright © 2012 International Hepato-Pancreato-Biliary Association Terms and Conditions

Figure 2 Overall survival HPB 2012 14, 60-66DOI: (10.1111/j.1477-2574.2011.00405.x) Copyright © 2012 International Hepato-Pancreato-Biliary Association Terms and Conditions